Back to results
US 2014/0271866 A1Published application
Transdermal drug delivery system containing rivastigmine
AssigneeNAL Pharmaceuticals, Ltd.
InventorJe Phil Ryoo
Life of this patent
Estimating the term…
Abstract
The present invention provides a transdermal drug delivery system comprising rivastigmine or its pharmaceutically acceptable salt and method of making the same.
Claims17
A transdermal drug delivery system comprising a drug-containing matrix layer comprising rivastigmine or its pharmaceutically acceptable salt and an acrylic-hydrocarbon hybrid polymer.
Dependencies are inferred from the claim text.